Anticholinesterases in post-poliomyelitis syndrome.
Trojan
D A
DA
Department of Neurology, Montreal Neurological Institute and Hospital, McGill University, Quebec, Canada.
Cashman
N R
NR
D004491:Edrophonium / Q000494:pharmacology / Q000627:therapeutic use*; D004576:Electromyography; D005221:Fatigue / Q000503:physiopathology; D006801:Humans; D009119:Muscle Contraction / Q000187:drug effects; D009469:Neuromuscular Junction / Q000503:physiopathology; D016262:Postpoliomyelitis Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D011729:Pyridostigmine Bromide / Q000494:pharmacology*; D009435:Synaptic Transmission / Q000187:drug effects; D013997:Time Factors
D004491:Edrophonium; D011729:Pyridostigmine Bromide